Hydroxychloroquine Lowers the Risk for Diabetes Mellitus in Patients with Systemic

[1]  L. Arnaud,et al.  Hydroxychloroquine in systemic and auto-immune diseases: where are we now? , 2021, Joint bone spine.

[2]  H. Daoud,et al.  Coronary artery disease (CAD) risk factor analysis in an age-stratified hospital population with systemic lupus erythematosus (SLE) , 2020, International Journal of Cardiology. Hypertension.

[3]  Haojie Lu,et al.  The multi-targets mechanism of hydroxychloroquine in the treatment of systemic lupus erythematosus based on network pharmacology , 2020, Lupus.

[4]  R. Xavier,et al.  Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases , 2020, Advances in Rheumatology.

[5]  Ebrahim M Yimer,et al.  Potential Effect of Hydroxychloroquine in Diabetes Mellitus: A Systematic Review on Preclinical and Clinical Trial Studies , 2020, Journal of diabetes research.

[6]  J. Esdaile,et al.  Adherence to Antimalarial Therapy and Risk of Type 2 Diabetes Mellitus Among Patients With Systemic Lupus Erythematosus: A Population‐Based Study , 2020, Arthritis care & research.

[7]  A. Abdel-Hamid,et al.  Hydroxychloroquine hindering of diabetic isletopathy carries its signature on the inflammatory cytokines , 2016, Journal of Molecular Histology.

[8]  K. Rainsford,et al.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases , 2015, Inflammopharmacology.

[9]  Frederico G. S. Toledo,et al.  Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial , 2015, Diabetologia.

[10]  Jun-Sing Wang,et al.  Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study. , 2015, Rheumatology.

[11]  N. Thomas,et al.  Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone , 2014, Current medical research and opinion.

[12]  Xiaohua Douglas Zhang.  Contrast Variable Potentially Providing a Consistent Interpretation to Effect Sizes , 2010 .

[13]  B. Richelsen,et al.  Adiponectin: action, regulation and association to insulin sensitivity , 2005, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[14]  J. Chan,et al.  Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. , 2003, The Journal of clinical endocrinology and metabolism.

[15]  L. Magder,et al.  Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. , 1994, The American journal of medicine.

[16]  T. Leff,et al.  Adiponectin and PPARγ: cooperative and interdependent actions of two key regulators of metabolism. , 2012, Vitamins and hormones.